Cultivate your Potential.

Join ISCPDonate

Clinical Trials

Heart Failure

PARAMOUNT: Prospective Comparison of ARNI with ARB on Management of Heart Failure with Preserved Ejection Fraction

Scott Solomon et al.

RELAX TRIAL: Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

Jhon Teerlink, Gad Cotter,Beth Davison, et al

: PARADIGM-HF. Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, et al

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

Pablo Avanzas

Effect of Loading Dose of Atorvastatin Prior to Planned PCI: The SECURE-PCI Randomized Clinical Trial

Alberto J. Lorenzatti

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

Pablo Avanzas

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF) Study

Koji Hasegawa

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Celso Amodeo

Impact of Renin–Angiotensin System Inhibitors on Transcatheter Aortic Valve Replacement: Analysis from PARTNER 2

Pablo Avanzas

Targeted Anti-Cytokine Therapies for Treatment of Atherothrombosis

Pablo Avanzas

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Edgardo Escobar

Angiotensin-Neprilysin Inhibition as the First-Line Therapy for HF over ACE inhibitors?

Koji Hasegawa

Stay updated

ISCP Newsletter

Sign up to receive news and updates on our iniciatives, content and events.